C Scheidereit
Overview
Explore the profile of C Scheidereit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
3532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weichert W, Boehm M, Gekeler V, Bahra M, Langrehr J, Neuhaus P, et al.
Br J Cancer
. 2007 Jul;
97(4):523-30.
PMID: 17622249
Activation of nuclear factor-kappaB (NF-kappaB) signaling was observed in pancreatic adenocarcinoma cell lines and tumours. However, information on the expression of RelA/p65, the major transcription activating NF-kappaB subunit, in these...
2.
Scheidereit C
Verh Dtsch Ges Pathol
. 2006 Aug;
87:79-89.
PMID: 16888898
In the recent years, progress has been made in defining the lineage origin of malignant cells of Hodgkin's disease. The use of single cell PCR analysis and of other molecular...
3.
Schmidt-Ullrich R, Aebischer T, Hulsken J, Birchmeier W, Klemm U, Scheidereit C
Development
. 2001 Oct;
128(19):3843-53.
PMID: 11585809
NF-kappaB/Rel transcription factors and IkappaB kinases (IKK) are essential for inflammation and immune responses, but also for bone-morphogenesis, skin proliferation and differentiation. Determining their other functions has previously been impossible,...
4.
Krappmann D, Patke A, Heissmeyer V, Scheidereit C
Mol Cell Biol
. 2001 Sep;
21(19):6640-50.
PMID: 11533251
Antigen receptor signaling is known to activate NF-kappaB in lymphocytes. While T-cell-receptor-induced NF-kappaB activation critically depends on novel protein kinase C theta (PKCtheta), the role of novel PKCs in B-cell...
5.
Muller D, Heissmeyer V, Dechend R, Hampich F, Park J, Fiebeler A, et al.
FASEB J
. 2001 Aug;
15(10):1822-4.
PMID: 11481242
No abstract available.
6.
Wuchter C, Krappmann D, Cai Z, Ruppert V, Scheidereit C, Dorken B, et al.
Leukemia
. 2001 Jun;
15(6):921-8.
PMID: 11417478
The TNF-related apoptosis-inducing ligand (TRAIL) is currently under evaluation as a possible (co-)therapeutic in cancer treatment. We therefore examined 129 cell samples from patients with de novo acute leukemia as...
7.
Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C
Blood
. 2001 Apr;
97(9):2798-807.
PMID: 11313274
Constitutively activated nuclear factor (NF)-kappaB is observed in a variety of neoplastic diseases and is a hallmark of the malignant Hodgkin and Reed-Sternberg cells (H/RS) in Hodgkin lymphoma. Given the...
8.
Slaugenhaupt S, Blumenfeld A, Gill S, Leyne M, Mull J, Cuajungco M, et al.
Am J Hum Genet
. 2001 Feb;
68(3):598-605.
PMID: 11179008
Familial dysautonomia (FD; also known as "Riley-Day syndrome"), an Ashkenazi Jewish disorder, is the best known and most frequent of a group of congenital sensory neuropathies and is characterized by...
9.
Heissmeyer V, Krappmann D, Hatada E, Scheidereit C
Mol Cell Biol
. 2001 Feb;
21(4):1024-35.
PMID: 11158290
p105 (NFKB1) acts in a dual way as a cytoplasmic IkappaB molecule and as the source of the NF-kappaB p50 subunit upon processing. p105 can form various heterodimers with other...
10.
Krappmann D, Hatada E, Tegethoff S, Li J, Klippel A, Giese K, et al.
J Biol Chem
. 2000 Jul;
275(38):29779-87.
PMID: 10893415
A critical step in the activation of NF-kappa B is the phosphorylation of I kappa Bs by the I kappa B kinase (IKK) complex. IKK alpha and IKK beta are...